Aims: To investigate the frequency of thyroid dysgenesis (TD) in first-degree relatives of TD cases. Methods: 244 first-degree relatives of 82 TD cases were screened by thyroid ultrasound (USG), T4, fT4 and TSH. USG was also performed in 220 unrelated, age- and sex-matched healthy controls to obtain normative data for thyroid volumes. Results: Specific diagnoses of indexes were 35 ectopia, 22 athyreosis, 14 severe hypoplasia, 8 hypoplasia, and 3 hemiagenesis/asymmetric hypoplasia. In 5 of 77 families (6.5%), there were 2 cases with known symptomatic TD. A total of 10 cases made familial symptomatic TD ratio 12% (10/82) in our cohort. Screening of 244 asymptomatic family members did not reveal new cases with overt hypothyroidism. However, low thyroid volume in 15 and slightly elevated TSH in 6 family members and both in 1 family member were detected (7.4% for low thyroid volume, 3.2% for high TSH). Thus, the ratio of affected (symptomatic and asymptomatic) family members among families of TD cases was found to be 8.7%. Conclusions: 12% of TD cases are familial in our cohort. Screening of asymptomatic family members of TD revealed an additional 7.4% mild hypoplasia and 3.2% hyperthyrotropinemia without overt hypothyroidism which points out the importance of genetic factors in pathogenesis.

1.
Kaplan EL, Sugg SL: Surgery of the thyroid; in Degroot LJ, Jameson JL (eds): Endocrinology, ed 4. Philadelphia, Saunders, 2001, vol 2, pp 1567–1608.
2.
Castanet M, Polak M, Bonaiti-Pellie C, Lyonnet S, Czernichow P, Leger J, on behalf of Association Française pour le Dépistage et la Prévention des Handicaps de l’Enfant (AFDPHE): Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 2001;86:2009–2014.
3.
Leger J, Marinovic D, Garel C, Bonaiti-Pellie C, Polak M, Czernichow P: Thyroid developmental anomalies in first-degree relatives of children with congenital hypothyroidism. J Clin Endocrinol Metab 2002;87:575–580.
4.
Yordam N, Ozon A, Alikasifoglu A, Genc N, Kandemir N: Results of neonatal screening for congenital hypothyroidism in Turkey: Hacettepe experience. Horm Res 2003;60:100.
5.
Bereket A, Liao XH, Turoglu T, Aribal E, Refetoff S: Analysis of the PAX8 gene in congenital hypothyroidism caused by different forms of thyroid dysgenesis in a father and daughter. J Pediatr Endocrinol Metab 2004;17:1021–1029.
6.
Tuncbilek E, Koc I: Consanguineous marriage in Turkey and its impact on fertility and mortality. Ann Hum Genet 1994;58:321–329.
7.
Castanet M, Lyonnet S, Bonaiti C, Polak M, Czernichow P, Leger J: Familial forms of thyroid dysgenesis among infants with congenital hypothyroidism. N Engl J Med 2000;343:441–442.
8.
Camilot M, Teofoli F, Gandini A, Franceschi R, Rapa A, Corrias A, Bona G, Radetti G, Tatò L: Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygotes. Clin Endocrinol (Oxf) 2005;63:146–151.
9.
De Felice M, Di Lauro R: Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004;25:722–746.
10.
Connelly JF, Rickards AL, Coakley JC, Price GJ, Francis I, Mathur KS, Wolfe R: Newborn screening for congenital hypothyroidism, Victoria, Australia. J Pediatr Endocrinol Metab 2001;14:1611–1634.
11.
Toromanovic A, Tahirovic H: Thyroid volume and urinary iodine excretion in schoolchildren in North-Eastern Bosnia. Eur J Pediatr 2004;163:270–271.
12.
Semiz S, Senol U, Bircan, Gumuslu S, Bilmen S, Bircan I: Correlation between age, body size and thyroid volume in an endemic area. J Endocrinol Invest 2001;24:5595–5563.
13.
Semiz S, Senol U, Bircan O, Gumuslu S, Akcurin S, Bircan I: Thyroid gland volume and urinary iodine excretion in children 6–11 years old in an endemic area. J Pediatr Endocrinol Metab 2000;13:245–251.
14.
Tas F, Bulut S, Egilmez H, Oztoprak I, Ergur AT, Candan F: Normal thyroid volume by ultrasonography in healthy children. Ann Trop Paediatr 2002;22:375–379.
15.
Kurtoglu S, Covut IE, Kendirci M, Uzum K, Durak AC, Kırış A: Normal thyroid volume of children in Turkey: pilot study in Kayseri Province. IDD Newslett 1995;11:41–42.
16.
Sobrero G, Muñoz L, Bazzara L, Martin S, Silvano L, Iorkansky S, Bergoglio L, Spencer C, Miras M. Thyroglobulin reference values in a pediatric infant population. Thyroid 2007;17:1049–1054.
17.
Djemli A, Fillion M, Belgoudi J, Lambert R, Delvin EE, Schneider W, Van Vliet G: Twenty years later: a re-evaluation of the contribution of plasma thyroglobulin to the diagnosis of thyroid dysgenesis in infants with congenital hypothyroidism. Clin Biochem 2004;37:818–822.
18.
Sellitti DF, Akamizu T, Doi SQ, Kim GH, Kariyil JT, Kopchik JJ, Koshiyama H: Renal expression of two ‘thyroid-specific’ genes: thyrotropin receptor and thyroglobulin. Exp Nephrol 2000;8:235–243.
19.
Slominski A, Wortsman J, Kohn L, Ain KB, Venkataraman GM, Pisarchik A, Chung JH, Giuliani C, Thornton M, Slugocki G, Tobin DJ: Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol 2002;119:1449–1455.
20.
Czernichow P, Schlumberger M, Pomarede R, Fragu P: Plasma thyroglobulin measurements help determine the type of thyroid defect in congenital hypothyroidism. J Clin Endocrinol Metab 1983;56:242–245.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.